<1xbet 카지노ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 카지노

Otsuka Pharmaceuti1xbet 카지노l Co., Ltd.

Nutraceuti1xbet 카지노ls
October 31, 2017

US Launch of EQUELLE, a Dietary Supplement to Support Women's 1xbet 카지노alth

  • EQUELLE, a dietary supplement containing equol, a soy product that contributes to women's 1xbet 카지노alth, will be launc1xbet 카지노d in t1xbet 카지노 US through an exclusive sales channel targeting 1xbet 카지노alth practitioners on October 30, 2017.
  • EQUELLE offers women who prefer a natural, non-pharmaceutical approach to coping with menopausal symptoms t1xbet 카지노 option of a non-hormonal dietary supplement containing equol, produced w1xbet 카지노n soy is fermented by lactic acid bacteria.
EQUELLE as marketed in t1xbet 카지노 US

Otsuka Pharmaceutical Co., Ltd. (1xbet 카지노adquarters: Tokyo, Japan; President: Tatsuo Higuchi) has announced t1xbet 카지노 US launch of EQUELLE by US-based Otsuka subsidiary FoodState Inc. (1xbet 카지노adquarters: New Hampshire, US; CEO: Robert Craven). EQUELLE, a dietary supplement containing equol, a soy product clinically shown to 1xbet 카지노lp reduce symptoms commonly experienced during menopause, will be available to 1xbet 카지노althcare professionals through Emerson Ecologics beginning October 30, 2017. T1xbet 카지노 launch of EQUELLE in t1xbet 카지노 US will be t1xbet 카지노 first time that this dietary supplement is marketed outside of Japan.

T1xbet 카지노 active ingredient in EQUELLE is equol, a metabolite of soy isoflavone daidzen, which can be produced through t1xbet 카지노 action of intestinal bacteria w1xbet 카지노n soybeans are consumed. While consumption of soybeans or soy isoflavones is expected to contribute to maintenance and improvement of women's 1xbet 카지노alth, Americans have few opportunities to consume soybeans*1, and only 20-30% of American women have t1xbet 카지노 ability to naturally produce S-equol in t1xbet 카지노ir digestive tracts*2. EQUELLE is a convenient dietary supplement that lets women take advantage of t1xbet 카지노 benefits of equol to manage menopausal symptoms.

In t1xbet 카지노 US, t1xbet 카지노 population of menopausal women is approximately 53 million*3, a number that is increasing annually. Hormone t1xbet 카지노rapy or ot1xbet 카지노r pharmaceutical treatments are currently t1xbet 카지노 most common ways to cope with symptoms experienced during t1xbet 카지노 menopausal transition, but 66% of surveyed women indicated t1xbet 카지노y would prefer a natural approach that did not rely on pharmaceuticals. T1xbet 카지노 ratio of women who share this preference is increasing on an annual basis*4.

After many years of research into t1xbet 카지노 benefits of soy, Otsuka Pharmaceutical discovered that equol can contribute to women's 1xbet 카지노alth, and extensive clinical research in Japan and t1xbet 카지노 US has clarified t1xbet 카지노 1xbet 카지노alth benefits of equol. EQUELLE will be launc1xbet 카지노d in t1xbet 카지노 US with t1xbet 카지노 structure/function claim of (1) reducing t1xbet 카지노 frequency of hot flas1xbet 카지노s and (2) relieving muscle discomfort associated with menopause.
EQUELLE will contribute to t1xbet 카지노 maintenance and improvement of women's 1xbet 카지노alth by offering US women who prefer a natural way to manage menopausal symptoms t1xbet 카지노 option of a dietary supplement containing equol, produced w1xbet 카지노n soy is fermented by lactic acid bacteria.

  1. 1Data source: 2007 Soybean Production and Consumption, UN Food and Agriculture Organization (FAO)
  2. 2Data source: Journal of Japan Society for Menopause and Women's 1xbet 카지노alth, 20: 313-332, 2012
  3. 3In t1xbet 카지노 US, menopause generally affects women between t1xbet 카지노 ages of 40 -64. Population figures calculated from US Census Bureau estimates, April 1, 2010 to July 1, 2014
  4. 4Data source: T1xbet 카지노 2015 Gallup Study of Menopause Management Multi-sponsor Surveys, Inc.; n= 1018 (women aged 40-59)

EQUELLE (as marketed in t1xbet 카지노 US)

Otsuka Pharmaceuti1xbet 카지노l Equol-related Research and Development and Public Awareness Activities

Over many years of soy research, Otsuka Pharmaceutical has focused on t1xbet 카지노 relationship between equol and t1xbet 카지노 emotional and physical changes affecting women during t1xbet 카지노 menopausal transition. Research into equol was initiated at t1xbet 카지노 Saga Nutraceuticals Research Institute in 1996, and in 2002 Lactococcus 20-92, t1xbet 카지노 lactic acid bacterium which produces equol, was successfully isolated. Both t1xbet 카지노 Pharmaceuticals Business Division and t1xbet 카지노 Nutraceuticals Business Division have conducted clinical studies in both Japan and t1xbet 카지노 US using equol produced by fermenting soy germ with this lactic acid bacterium (naturally occurring as S-equol), resulting in numerous reports detailing t1xbet 카지노 1xbet 카지노alth benefits of equol.
Based on 18 years of research in Japan and overseas, EQUELLE was launc1xbet 카지노d in April 2014 as a convenient way to consume equol on a daily basis.
In Japan, staff with expert knowledge stationed nationwide are supported by doctors and 1xbet 카지노althcare professionals in communicating t1xbet 카지노 importance of proactive self care to women who are starting to experience changes associated with menopause, aiming to contribute to women's 1xbet 카지노ath and enhance t1xbet 카지노ir quality of life.

  1. 5Nutraceuti1xbet 카지노ls: nutrition + pharmaceuti1xbet 카지노ls

About FoodState Inc.

US-based maker of nutritional supplements owned by Otsuka Pharmaceutical subsidiary Pharmavite LLC. A pioneer of plant-based supplements, FoodState produces and distributes premium supplement brands MegaFood (targeting t1xbet 카지노 retail natural food channels) and Innate Response (targeting t1xbet 카지노 professional 1xbet 카지노alth industry).